A double-blind, randomized, placebo-controlled evaluation of the efficacy and safety of hydrocortisone buteprate 0.1% cream in the treatment of psoriasis

Advances in Therapy

Volumn 14, Issue 3, 1997, Pages 140-149

  Sears, Howard W ^a  

^a Clinical Research Bailer Research Inc   (United States)

Author keywords

Clinical trial; Corticosteroid; Glucocorticoid; Hydrocortisone buteprate; Nonhalogenated corticosteroid; Psoriasis; Topical agents

Indexed keywords

CORTICOSTEROID; GLUCOCORTICOID; HYDROCORTISONE 17 BUTYRATE 21 PROPIONATE; PLACEBO; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DISEASE DURATION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PSORIASIS; RANDOMIZED CONTROLLED TRIAL; SKIN DISEASE; TOPICAL DRUG ADMINISTRATION; TREATMENT OUTCOME; UPPER RESPIRATORY TRACT INFECTION;

EID: 0030842118     PISSN: 0741238X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Lebwohl M, Abel E, Zanolli M, Koo J, Drake L. Topical therapy for psoriasis. Int J Dermatol. 1995; 34:673-684.
2. Greaves MW, Weinstein GD. Treatment of psoriasis. N Engt J Med. 1995;332:581-588.
3. Farber EM. Therapeutic perspectives in psoriasis. Int J Dermatol. 1995;4:456-460.
4. Raychaudhuri SP, Rein G, Farber EM. Neuropathogenesis and neuropharmacology of psoriasis. Int J Demmlol. 1995;34:685-693.
5. Abel EA, DiCicco LM, Orenberg EK, et al. Drugs in exacerbation of psoriasis. J Am Acad Dermalol 1986;15:1007-1022.
6. Phillips TJ. Current treatment options in psoriasis. Hasp Pract. 1996;31:155-166.
7. Kirsner RS, Federman D. Treatment of psoriasis: Role of calcipotriene. Am Fam Physician. 1995; 52:237-240.
8. Data on file, Savage Laboratories, Melville, New York.
9. Lane AT, Wachs GN, Weston WL. Once-daily treatment of psoriasis with glucocorticosteroid ointments. J Am Acad Dermatol. 1983;8:523-525.